Dr. John C. Wang, MD

Dr. Wang practices at MedStar Union Memorial Hospital in Baltimore, Maryland, part of MedStar Health.

Dr. Wang's NPI, 1396739009, was assigned on September 8, 2005. Dr. Wang graduated from Pritzker School of Medicine in 1997. Dr. Wang's Maryland license number on file is D0061276.

Dr. Wang's primary practice is MedStar Union Memorial Hospital, at 201 East University Parkway, Baltimore, MD 21218 in Baltimore City. The practice phone is (410) 554-2227.

Dr. Wang's primary practice is MedStar Union Memorial Hospital in Baltimore, Maryland, part of MedStar Health. Dr. Wang is also affiliated with Mercy Medical Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Wang to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Wang is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Wang's licenses on file in 2 states: Maryland and Massachusetts.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac catheterization, heart attack, heart valve disorders, heart valve surgery and pacemaker or defibrillator implantation among the conditions Dr. Wang treats.

CMS data shows 676 Medicare services from Dr. Wang across 15 procedure codes in 2024, for 488 Medicare patients. Medicare paid $175,975 for them.

CMS counts 488 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 228 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 71, with 46% women.

In 2024, Dr. Wang wrote 11 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 143 procedures of coronary angioplasty and stenting by Dr. Wang, more than 98% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 35 papers to Dr. Wang, published from 2010 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Drug-Eluting Stents, Prosthesis Design and Coronary Artery Disease. Dr. Wang has published most often in Cardiovasc Revasc Med. Dr. Wang's most frequent co-authors are Ron Waksman, MD, Brian Christopher Case, MD and Tamim Michael Nazif, MD.

Dmand AI links Dr. Wang to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Atherosclerosis, Coronary Artery Disease and Ventricular Outflow Obstruction. Boston Scientific Corporation sponsors the most, 2.

CMS Open Payments shows 717 general payments to Dr. Wang from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Abbott Laboratories paid the most, $112,656.

Dmand AI lists 2 awards for Dr. Wang.

Dr. Wang graduated from Pritzker School of Medicine in 1997. Dr. Wang is a member of ACC and SCAI.

Dr. Wang is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.